PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

The FDA Just Shut Down 503B Compounded Semaglutide | DOWNSIZED LIVE!

Patient storyDOWNSIZED7,923 views2:21:08Jun 2025

Our summary

A patient explains how Zepbound works and what the evidence says. A weight loss of 50 lb is mentioned. Side effects mentioned: nausea, constipation and fatigue. Also covers food, protein and eating, food noise and cravings and injection technique.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Introduction
  2. 0:14 Compounded semaglutide news
  3. 2:29 Court ruling details
  4. 5:49 Future of compounding
  5. 8:07 Novo Nordisk price offer
  6. 9:29 GLP-1 market dynamics
  7. 12:25 Cruise updates and Q&A
  8. 17:32 Patent news and medication tips

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound and semaglutide
Weight loss mentioned
50 lb
Side effects mentioned
nausea, constipation and fatigue
Who is speaking
Patient

Find more like it

Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsInjection techniqueCost and insuranceExercise and strengthAlcoholStopping and maintenance

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV